Goodwill And Other Intangible Assets

9 Months Ended

Oct. 01, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

GOODWILL AND OTHER INTANGIBLE ASSETS

The following is a rollforward of the Company’s goodwill ($ in millions):

Balance, December 31, 2020	$	35,420
Attributable to 2021 acquisitions	6,899
Attributable to 2021 divestitures	(12)
Adjustments due to finalization of purchase price allocations	(12)
Foreign currency translation and other	(1,058)
Balance, October 1, 2021	$	41,237

The carrying value of goodwill by segment is summarized as follows ($ in millions):

	October 1, 2021		December 31, 2020
Life Sciences	$	31,755	$	25,812
Diagnostics	6,974		7,082
Environmental & Applied Solutions	2,508		2,526
Total	$	41,237	$	35,420

The Company has not identified any “triggering” events which indicate an impairment of goodwill in 2021.

The Company reviews identified intangible assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. The Company identified impairment triggers during both the first quarters of 2021 and 2020 and during the third quarter of 2020 which resulted in the impairment of certain long-lived assets, including trade names and other intangible assets. The Company recorded impairment charges totaling $10 million in the nine-month period ended October 1, 2021 and $14 million and $22 million in the three and nine-month periods ended October 2, 2020, respectively, related to these long-lived assets.